| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |